Cassava Sciences Announces Initiation of an Open-Label Study to Evaluate PTI-125 in Patients with Alzheimer’s Disease

    NEXT STORY
    Children’s Hospital of Georgia uses Philips’ automated early detection and warning solution to improve pediatric patient deterioration response
    PREV STORY
    Physician-led Online Healthcare Technology Company Applies for Novel Clinical Trial for COVID-19 Using Medical Cannabis
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Chembio to Report Third Quarter 2018 Financial Results on November 8, 2018

    MEDFORD, N.Y., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a ...

    author_avatar
    NASDAQ Market News

    Roche to present new data demonstrating the breadth and depth of its Alzheimer’s programme at the upcoming Alzheimer’s Association International Conference

    Late-breaking Phase II exploratory analysis of investigational crenezumab to show impact on amyloid beta ...

    author_avatar
    NASDAQ Market News

    Selecta Biosciences to Present at Two Upcoming Investor Conferences in May

    WATERTOWN, Mass., April 26, 2017 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq:SELB), a clinical-stage ...

    author_avatar
    NASDAQ Market News